Oncology Institute, Inc.
Current- Director 2024 to present
Skip to record
Executive record
Alpha ID: alpha:person:daniel-virnichVersion: public-0As of: 2026-10-01
Not yet claimed9 published Claims5 sources
- Director
Leadership, in context.
Connect capital, control, accountability, and evidence.
Explore the record
ResponsibilitiesInspect board appointments and committee mandates.ExperienceReview career history and qualifications in context.Economic interestsExamine disclosed incentives and ownership.Key Claims
Biography
Served as CEO since June 2023, previously President and Chief Operating Officer. Prior experience includes market president at DaVita Medical Group and Chief Medical Officer at TeamHealth Acute Care Services. Holds MD from Pritzker School of Medicine and MBA from Kellogg School of Management.
Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.
Board service
Boards
Claims
Executive career
- 2026 to end not publishedExecutive title: Chief Executive Officer · Organization not publishedTOI DEF 14A director slate
Claims
Compensation
Compensation coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageConflicts and accountability
Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.
Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.
Evidence, history and coverage
Additional published Claims
Published evidence records
5 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.
TOI DEF 14A executive officers
sec filing · Source published: Apr 30, 2026 · Retrieved: Jul 28, 2026
Supports 5 claims
- AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
- Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 16, 2026
- Executive company: Executive at The Oncology Institute, Inc. · Claim reviewed: Jul 28, 2026
- Executive title: Executive title: Chief Executive Officer · Claim reviewed: Jul 28, 2026
- Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 16, 2026
DFPH DEF 14A executive officers
sec filing · Source published: Apr 30, 2026 · Retrieved: May 16, 2026
Supports 2 claims
- Executive company: Executive at The Oncology Institute, Inc. · Claim reviewed: Jul 28, 2026
- Executive title: Executive title: Chief Executive Officer · Claim reviewed: Jul 28, 2026
TOI DEF 14A director slate
sec filing · Source published: Mar 27, 2025 · Retrieved: Jul 28, 2026
Supports 7 claims
- AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
- Board role: Board role: Director · Claim reviewed: Jul 28, 2026
- Committee assignments: No committee assignment disclosed in the cited filing · Claim reviewed: Jul 28, 2026
- Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 16, 2026
- Executive company: Executive at The Oncology Institute, Inc. · Claim reviewed: Jul 28, 2026
- Executive title: Executive title: Chief Executive Officer · Claim reviewed: Jul 28, 2026
- Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 16, 2026
Open source
sec proxy · Source published: Mar 27, 2025 · Retrieved: Apr 28, 2026
Supports 1 claim
- Professional Role: Director at Oncology Institute, Inc. · Claim reviewed: May 16, 2026
Open source
public source · Source published: Date unavailable · Retrieved: Date unavailable
Supports 1 claim
- Board membership: Serves on the board of Oncology Institute, Inc. · Claim reviewed: May 16, 2026
No published record changes are available in this projection.
Identity
unclaimed
Evidence
corroborated
Evaluation
Unknown
Monitoring
Unknown
Authority
Unknown
Freshness
Observed 2026-10-01
- Biography
- published
- Board service
- published
- Executive career
- published
- Education and qualifications
- not observed
- Compensation
- not observed
- Conflicts and accountability
- not observed
- Background screening
- out of scope